Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa
Date: August 13, 2018
Issue #:
1553Summary:
The FDA has approved a 6% otic suspension
formulation of the fluoroquinolone antibiotic
ciprofloxacin (Otiprio– Otonomy) for single-dose
treatment of acute otitis externa (swimmer ' s
ear) caused byPseudomonas aeruginosa orStaphylococcus aureus in patients≥6 months old.Otiprio was approved earlier for prophylaxis in
children with bilateral otitis media with effusion who
are undergoing tympanostomy tube placement.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Ciprodex Ciprofloxacin Dexamethasone Fluoroquinolones Hydrocortisone Neomycin Ocuflox Otiprio Otitis media Pseudomonas aeruginosa Stapylococcus aureus Source Type: research
More News: Children | Cipro | Ciprofloxacin | Dexamethasone | Drugs & Pharmacology | Hydrocortisone | Otitis | Otitis Externa (Swimmer's Ear) | Otitis Media